Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4981 AL 4995

Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences

Peters ME, Vaidya V, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Avramopoulos D; CitAD Research Group.

J Geriatr Psychiatry Neurol. 2016 Mar;29(2):59-64. doi: 10.1177/0891988715601735. Epub 2015 Aug 23.

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Weintraub D, Newell J, Yesavage J, Lyketsos CG; CitAD Research Group.

Int Psychogeriatr. 2015 Dec;27(12):2059-67. doi: 10.1017/S1041610215001106. Epub 2015 Aug 25.

Interventions for Neuropsychiatric Symptoms in Neurocognitive Impairment Due to Alzheimer's Disease: A Review of the Literature

McClam TD, Marano CM, Rosenberg PB, Lyketsos CG.

Harv Rev Psychiatry. 2015 Sep-Oct;23(5):377-93. doi: 10.1097/HRP.0000000000000097.

Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services

Wattmo C, Londos E, Minthon L.

Dement Geriatr Cogn Disord. 2015;40(5-6):297-310. doi: 10.1159/000437050. Epub 2015 Sep 4.

Alzheimer's disease and language impairments: social intervention and medical treatment

Klimova B, Maresova P, Valis M, Hort J, Kuca K.

Clin Interv Aging. 2015 Aug 27;10:1401-7. doi: 10.2147/CIA.S89714. eCollection 2015.

Treatment Options in Alzheimer´s Disease: The GABA Story

Solas M, Puerta E, Ramirez MJ.

Curr Pharm Des. 2015;21(34):4960-71. doi: 10.2174/1381612821666150914121149.

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Santamato A, Lozupone M, Prete C, Greco A, Pilotto A, Logroscino G.

Expert Opin Pharmacother. 2015;16(17):2581-8. doi: 10.1517/14656566.2015.1092520. Epub 2015 Sep 21.

Dextromethorphan and Quinidine for Treating Agitation in Patients With Alzheimer Disease Dementia

Ballard C, Sharp S, Corbett A.

JAMA. 2015 Sep 22-29;314(12):1233-5. doi: 10.1001/jama.2015.10215.

Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial

Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PN, Siffert J.

JAMA. 2015 Sep 22-29;314(12):1242-54. doi: 10.1001/jama.2015.10214.

Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Matsunaga S, Kishi T, Annas P, Basun H, Hampel H, Iwata N.

J Alzheimers Dis. 2015;48(2):403-10. doi: 10.3233/JAD-150437.

Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial

Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Pilcher G, Ferris S, Colby S, Kerselaers W, Dockens R, Soares H, Kaplita S, Luo F, Pachai C, Bracoud L, Mintun M, Grill JD, Marek K, Seibyl J, Cedarbaum JM, Albright C, Feldman HH, Berman RM.

JAMA Neurol. 2015 Nov;72(11):1324-33. doi: 10.1001/jamaneurol.2015.0607.

CAP--advancing the evaluation of preclinical Alzheimer disease treatments

Reiman EM, Langbaum JB, Tariot PN, Lopera F, Bateman RJ, Morris JC, Sperling RA, Aisen PS, Roses AD, Welsh-Bohmer KA, Carrillo MC, Weninger S.

Nat Rev Neurol. 2016 Jan;12(1):56-61. doi: 10.1038/nrneurol.2015.177. Epub 2015 Sep 29.

IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia

Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, Chan M, Ghassemi A.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):106-112. doi: 10.1136/jnnp-2015-311486. Epub 2015 Sep 29.

A case of donepezil-related torsades de pointes

Kitt J, Irons R, Al-Obaidi M, Missouris C.

BMJ Case Rep. 2015 Oct 5;2015:bcr2015211900. doi: 10.1136/bcr-2015-211900.

Protein structures in Alzheimer's disease: The basis for rationale therapeutic design

Montoliu-Gaya L, Villegas S.

Arch Biochem Biophys. 2015 Dec 15;588:1-14. doi: 10.1016/j.abb.2015.10.005. Epub 2015 Oct 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias